| Cardiovascular risk factors in primary hyperparathyroidism. | |
| | |
MedLine Citation:
|
PMID: 19636198 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND AND AIMS: Severe primary hyperparathyroidism (PHP) has been associated with increased cardiovascular morbidity. Such an association in mild PHP is not known. We conducted a cross-sectional study to assess the correlation between mild and traditional PHP and emergent cardiovascular risk factors. SUBJECTS AND METHODS: A total of 139 patients with PHP (72 with severe PHP and indications for parathyroidectomy, 67 with mild PHP and no indications for surgery) and 111 control subjects, of similar age and body weight, were enrolled in this study. Participants had measurement of fasting blood levels of calcium, PTH, insulin, glucose, total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, interleukin-6, and C-reactive protein. Body mass index (BMI), waist and hip circumferences, blood pressure, homeostasis model assessment 2-insulin resistance index (IR) and the presence of metabolic syndrome (MS) were evaluated. RESULTS: Severe PHP patients had significantly higher rates of MS (37.5%), IR (38.9 %) vs mild PHP (34.3 and 23.9%, respectively) and controls (14.4 and 14.4%, respectively). Multivariate logistic-regression model, adjusted for age and BMI, and for age and waist size, revealed that severe PHP had significantly higher likelihood of cardiovascular risks [odds ratio (OR) 3.5, 95% confidence interval (CI) 1.5-8.125, p=0.004 for MS, and OR 3.7, 95% CI 1.64-8.29, p=0.002 for IR]. Serum calcium significantly predicted the presence of MS (OR 1.875, 95% CI 1.259-2.793, p=0.002) and IR (OR 2.043, 95% CI 1.365-3.057, p=0.002). CONCLUSIONS: Greater probability of MS and insulin resistance was observed in patients with severe PHP. Serum calcium is a predictor of these cardiovascular risk factors. |
| | |
Authors:
|
R Luboshitzky; Y Chertok-Schaham; I Lavi; A Ishay |
Related Documents
:
|
19762608 - Clinical implication of metabolic syndrome on chronic kidney disease depends on gender ... 21563348 - Risk adjustment under the affordable care act: a guide for federal and state regulators. 21593228 - Risk of venous thromboembolism with drospirenone-containing oral contraceptives. 22197438 - Age-related macular degeneration and incident cardiovascular disease: the multi-ethnic ... 16049588 - Coagulation gene polymorphisms as risk factors for myocardial infarction in young india... 16537858 - Does antibiotic exposure during infancy lead to development of asthma?: a systematic re... |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: Journal of endocrinological investigation Volume: 32 ISSN: 1720-8386 ISO Abbreviation: J. Endocrinol. Invest. Publication Date: 2009 Apr |
Date Detail:
|
Created Date: 2009-07-28 Completed Date: 2009-10-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7806594 Medline TA: J Endocrinol Invest Country: Italy |
Other Details:
|
Languages: eng Pagination: 317-21 Citation Subset: IM |
Affiliation:
|
Endocrine Institute, Haemek Medical Center, 18101 Afula, Israel. Luboshitzky_r@clalit.org.il |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Blood Glucose
/
metabolism Blood Pressure Body Mass Index C-Reactive Protein / metabolism Cardiovascular Diseases / blood, etiology* Case-Control Studies Cholesterol, HDL / blood Cholesterol, LDL / blood Cross-Sectional Studies Female Humans Hyperparathyroidism, Primary / blood, complications* Insulin / blood Insulin Resistance Interleukin-6 / blood Male Middle Aged Risk Factors Triglycerides / blood |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Interleukin-6; 0/Triglycerides; 11061-68-0/Insulin; 9007-41-4/C-Reactive Protein |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Adrenocorticotropin-independent Cushing's syndrome in pregnancy related to overexpression of adrenal...
Next Document: A novel mutation in the N-terminal region of the CYP17A1 gene in a patient with 17alpha-hydroxylase/...